The individuals behind Purdue Pharma’s involvement in the U.S. opioid crisis reached a $7-billion settlement in January 2025.
In addition, the Sackler family members will no longer control Purdue, which was blamed for helping to jumpstart the opioid crisis through its marketing of OxyContin. The company was accused of ...
Members of the family who own OxyContin maker Purdue Pharma, and the company itself, agreed to pay up to $7.4 billion in a ...